Full Name
Mu Li
(not current staff)
Mu, L.
Other emails


Results 1-9 of 9 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
19-Jan-2003A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGSMu, L. ; Feng, S.S. 
215-Jan-2006Application of TPGS in polymeric nanoparticulate drug delivery systemMu, L. ; Seow, P.H.
3Feb-2004Nanoparticles of biodegradable polymers for clinical administration of paclitaxelFeng, S.-S. ; Mu, L. ; Win, K.Y. ; Huang, G.
4Sep-2000Nanospheres of biodegradable polymers: A system for clinical administration of an anticancer drug paclitaxel (Taxol®)Feng, S.S. ; Huang, G.F.; Mu, L. 
518-Apr-2005Novel powder formulations for controlled delivery of poorly soluble anticancer drug: Application and investigation of TPGS and PEG in spray-dried particulate systemMu, L. ; Teo, M.-M.; Ning, H.-Z.; Tan, C.-S.; Feng, S.-S. 
6Nov-2003PLGA/TPGS Nanoparticles for Controlled Release of Paclitaxel: Effects of the Emulsifier and Drug Loading RatioMu, L. ; Feng, S.-S. 
731-May-2002Polymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol®)Feng, S.-S. ; Mu, L. ; Chen, B.-H. ; Pack, D.
8Jun-2000Study of synthesis and cardiovascular activity of some furoxan derivatives as potential NO-donorsMu, L. ; Feng, S.-S. ; Go, M.L. 
923-Apr-2002Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®)Mu, L. ; Feng, S.S